z-logo
Premium
Acute lymphoblastic leukemia relapse after CD19‐targeted chimeric antigen receptor T cell therapy
Author(s) -
Wang Jiasheng,
Hu Yongxian,
Huang He
Publication year - 2017
Publication title -
journal of leukocyte biology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.5ru0817-315r
Subject(s) - chimeric antigen receptor , cd19 , immunogenicity , immunology , bone marrow , leukemia , acute lymphocytic leukemia , biology , lymphoblastic leukemia , antigen , oncology , cancer research , t cell , medicine , immune system
Review of different mechanisms leading to ALL relapse after CAR‐t therapy, and different strategies to minimize the relapse.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here